TransMedics Group, Inc. appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective September 21, 2026, succeeding Gerardo Hernandez. Araujo brings prior CFO experience from GE HealthCare’s Advanced Imaging Solutions segment and 3M Enterprise Operations. His compensation includes a $590,000 annual base salary, a target bonus of 60% of base, a $200,000 sign-on bonus, and equity grants valued at approximately $1.75 million each in stock options and restricted stock units. Hernandez will transition to Commercial Strategic Advisor for Latin America through December 31, 2026, before serving as a non-employee senior advisor until April 30, 2027. Concurrently, the company reiterated its full-year 2026 revenue guidance of $737 million to $757 million, representing 22% to 25% year-over-year growth. TransMedics operates in the medical device industry, specializing in portable warm perfusion technology for donor organ preservation and assessment prior to transplantation.